Lee Ainslie - Maverick Capital
Holding/activity history for Caribou Biosciences, Inc. (CRBU)
← All CRBU superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 652,542 | 0.01 | $1.90 | $1,239,830 | SEC | ||
| 2025 Q4 | 652,542 | 0.01 | $1.59 | $1,037,542 | SEC | ||
| 2025 Q3 | 652,542 | 0.02 | $2.33 | $1,520,423 | SEC | ||
| 2025 Q2 | 652,542 | 0.01 | $1.26 | $822,203 | SEC | ||
| 2025 Q1 | 652,542 | 0.01 | $0.91 | $595,836 | SEC | ||
| 2024 Q4 | 652,542 | 0.02 | $1.59 | $1,037,542 | SEC | ||
| 2024 Q3 | 652,542 | 0.02 | $1.96 | $1,278,982 | SEC | ||
| 2024 Q2 | 652,542 | 0.02 | $1.64 | $1,070,169 | SEC | ||
| 2024 Q1 | 652,542 | 0.06 | $5.14 | $3,354,066 | SEC | ||
| 2023 Q4 | 652,542 | 0.07 | $5.73 | $3,739,066 | SEC | ||
| 2023 Q3 | 652,542 | 0.07 | $4.78 | $3,119,151 | SEC | ||
| 2023 Q2 | 652,542 | 0.06 | $4.25 | $2,773,304 | SEC | ||
| 2023 Q1 | 652,542 | 0.09 | $5.31 | $3,464,998 | SEC | ||
| 2022 Q4 | 652,542 | 0.10 | $6.28 | $4,097,964 | SEC | ||
| 2022 Q3 | 652,542 | 0.16 | $10.55 | $6,884,000 | SEC | ||
| 2022 Q2 | 652,542 | 0.09 | $5.43 | $3,543,000 | SEC | ||
| 2022 Q1 | 652,542 | 0.11 | $9.18 | $5,990,000 | SEC | ||
| 2021 Q4 | 652,542 | 0.11 | Reduce 31.49% | 0.07 | $14.17–24.00 · VW $19.19i | $9,748,000 | SEC |
| 2021 Q3 | 952,542 | 0.22 | Buy | 0.22 | $15.00–32.65 · VW $23.68i IPO/listing quarter |
$21,785,000 | SEC |
Price snapshot:
Current price$1.80
Avg. buy price$22.87
+/- since buy-92.13%
52-week low$1.38
52-week high$3.54